IP Library Granted Patent US 12,419,823
Granted Patent B2
US 12,419,823 · App. 17/600,010 · Granted Sep 23, 2025

Antimicrobial composition

Inventors: Ying Zhang (Woodbury, MN); Robert A. Asmus (Hudson, WI); Zhicheng Tian (Woodbury, MN); Kheng Vang (St. Paul, MN); James P. Dizio (St. Paul, MN); Patrick J. Parks (Mendota Heights, MN); Brian E. Spiewak (Inver Grove Heights, MN)
Assignee: Solventum Intellectual Properties Company
A61K8/4926A61K8/342A61K8/345A61K8/375A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,823
App. No.
17/600,010
Granted
Sep 23, 2025
Kind
B2
Abstract

Antimicrobial compositions containing an antimicrobial agent, such as an octenidine salt, a solubilizer, such as a glycol, and a cidatrope, such as a C 8 -C 26 alcohol, an ether, an amide, an ester, and combinations thereof, where the compositions are substantially free of water and C 2 -C 5 alcohols and methods of making such antimicrobial compositions.

Claims (24)

1. An antimicrobial composition comprising:

60 wt. % to 99.4 wt. % solubilizer, the solubilizer selected from glyceryl monoisostearate, glyceryl monooleate, decagylcerol hexaoleate, decagylcerol decaoleate, and a combination thereof;

0.1 wt. % to 10 wt. % antimicrobial agent, the antimicrobial agent selected from octenidine dihydrochloride, octenidine gluconate, octenidine sulfate, octenidine acetate, and a combination thereof; and

0.1 wt. % to 15 wt. % cidatrope, the cidatrope selected from diisopropyl adipate, dibutyl sebacate, triethyl citrate, acetyltributyl citrate, trioctyldodecyl citrate, PPG-10 butanediol, and a combination thereof,

wherein the composition is substantially free of water and a C 2 -C 5 alcohol.

2. The antimicrobial composition of claim 1 , wherein the solubilizer is glyceryl monoisostearate.

3. The antimicrobial composition of claim 1 , wherein the cidatrope is diisopropyl adipate, dibutyl sebacate, or a combination thereof.

4. The antimicrobial composition of claim 1 , wherein the cidatrope is selected from diisospropyl adipate, dibutyl sebacate, triethyl citrate, PPG-10 butanediol, and a combination thereof.

5. The antimicrobial composition of claim 1 , wherein the cidatrope is selected from the group consisting of triethyl citrate, acetyltributyl citrate, trioctyldodecyl citrate, and a combination thereof.

6. The antimicrobial composition of claim 1 , wherein the antimicrobial agent is octenidine dihydrochloride.

7. The antimicrobial composition of claim 1 , wherein the cidatrope and antimicrobial agent are present at a weight ratio of 8:1 to 10:1 cidatrope:antimicrobial agent.

8. The antimicrobial composition of claim 7 , wherein the solubilizer is glyceryl monoisostearate.

9. The antimicrobial composition of claim 8 , wherein the cidatrope selected from triethyl citrate, acetyltributyl citrate, trioctyldodecyl citrate, and a combination thereof.

10. The antimicrobial composition of claim 8 , wherein the cidatrope is selected from diisospropyl adipate, dibutyl sebacate, triethyl citrate, PPG-10 butanediol, and a combination thereof.

11. The antimicrobial composition of claim 7 , wherein the solubilizer is glyceryl monoisostearate and the antimicrobial agent is octenidine dihydrochloride.

12. The antimicrobial composition of claim 7 , wherein the cidatrope selected from triethyl citrate, acetyltributyl citrate, trioctyldodecyl citrate, and a combination thereof.

13. The antimicrobial composition of claim 7 , wherein the cidatrope is selected from diisospropyl adipate, dibutyl sebacate, triethyl citrate, PPG-10 butanediol, and a combination thereof.

14. The antimicrobial composition of claim 1 , wherein the solubilizer is glyceryl monoisostearate.

15. The antimicrobial composition of claim 1 , wherein the solubilizer is glyceryl monoisostearate and the antimicrobial agent is octenidine dihydrochloride.

16. A personal care product comprising the antimicrobial composition of claim 1 .

17. The personal care product of claim 16 , wherein the personal care product is selected from the group consisting of an antimicrobial dressing, a skin preparation, a bathing formulation, and a nasal spray.

18. A method of killing or inactivating microorganisms on a mammalian tissue, the method comprising:

contacting the mammalian tissue with an antimicrobial composition of claim 1 .

19. The method of claim 18 , wherein the solubilizer is glyceryl monoisostearate and the antimicrobial agent is octenidine dihydrochloride.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2021
From: ZHANG, YING; ASMUS, ROBERT A.; TIAN, ZHICHENG; VANG, KHENG; DIZIO, JAMES P.; PARKS, PATRICK J.; SPIEWAK, BRIAN E.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 057646/0623 →
Continuity (2)
Provisional Application 62827281 · Apr 1, 2019
Related Publication 20220105018A1 · Apr 7, 2022
References Cited (21)
US 5084096A · Stovicek · 1992 [cited by applicant]
US 5408022A · Imazato · 1995 [cited by applicant]
US 6440405B1 · Cooper · 2002 [cited by applicant]
US 8569384B2 · Asmus · 2013 [cited by applicant]
US 8623935B2 · Hobbs · 2014 [cited by applicant]
US 9028852B2 · Scholz · 2015 [cited by applicant]
US 20140294976A1 · Argembeaux · 2014 [cited by applicant]
EP 3150234 · 2017 [cited by applicant]
WO WO2002102244 · 2002 [cited by applicant]
WO WO2014100807 · 2014 [cited by applicant]
WO WO2014100807A1 · 2014 [cited by examiner]
WO WO2016102132 · 2016 [cited by applicant]
WO WO2016102133 · 2016 [cited by applicant]
WO WO2020043269A1 · 2020 [cited by examiner]
WO WO2020240337 · 2020 [cited by applicant]
Yoshioka K, Nishimura H, Himukai M, Iwashima A. The inhibitory effect of choline and other quaternary ammonium compounds on thiamine transport in isolated rat hepatocytes. Biochim Biophys Acta. May 28, 1985;815(3):499-5… [cited by examiner]
Wilson, Acetylcholine, McGraw Hill, 2022 (Year: 2022). [cited by examiner]
PubChem, Glyceryl Monostearate, CID 24699, created 2005, https://pubchem.ncbi.nlm.nih.gov/compound/Glyceryl-Monostearate (Year: 2005). [cited by examiner]
CAS STN search results, glyceryl stearate, entered 1984 (see attached) (Year: 1985). [cited by examiner]
Block, Disinfection, Sterilization and Preservation, Chapter 13, 4th Edition, 1991, pp. 225-255. [cited by applicant]
International Search Report for PCT International Application No. PCT/IB2020/052891, mailed on Jun. 4, 2020, 5 pages. [cited by applicant]